CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising product recalls due to microbial contamination
4.1.2. Growth in the medical device, pharmaceutical and biotechnology industries
4.1.3. Growing R&D investments in life sciences & rising food safety concerns
4.1.4. Increasing healthcare business and medical spending
4.2. Market Restraints & Challenges
4.2.1. Expensive cost of instruments
4.2.2. Lengthy approval procedures due to time-consuming and complex regulator standards
4.2.3. Lack of skilled professionals
4.3. Market Opportunities
4.3.1. Increasing preference of contract manufacturing
4.3.2. Emerging economies
CHAPTER 5 GLOBAL BIOBURDEN TESTING MARKET – BY PRODUCT
5.1. Instruments
5.1.1. Microscopes
5.1.2. Automated Microbial Identification Systems
5.1.3. PCR
5.1.4. Others
5.2. Consumables
5.2.1. Media, Reagents & Kits
5.2.2. Others
CHAPTER 6 GLOBAL BIOBURDEN TESTING MARKET – BY TEST TYPE
6.1. Aerobic Count
6.2. Anaerobic Count
6.3. Fungi Count
6.4. Spore Count
CHAPTER 7 GLOBAL BIOBURDEN TESTING MARKET – BY APPLICATION
7.1. Raw Material Testing
7.2. Medical devises Testing
7.3. In-Process Material Testing
7.4. Sterilisation Validation Testing
7.5. Equipment Cleaning Validation
CHAPTER 8 GLOBAL BIOBURDEN TESTING MARKET – BY END USER
8.1. Contract Manufacturing Organizations
8.2. Pharmaceutical & Biotechnology Companies
8.3. Microbial Testing Laboratories
8.4. Medical Device Manufacturers
8.5. Food & Beverage Manufacturers
CHAPTER 9 GLOBAL BIOBURDEN TESTING MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL BIOBURDEN TESTING MARKET - COMPANY PROFILES
10.1. Sigma-Aldrich Corporation
10.2. Charles River Laboratories International, Inc.
10.3. SGS S.A.
10.4. Wuxi Pharmatech (CAYMAN) Inc.
10.5. Becton Dickson and Company
10.6. Nelson Laboratories Inc.
10.7. Pacific Biolabs
10.8. ATS Labs Inc.
10.9. North American Science Associates, Inc.
10.10. Merck & Co. Inc.
10.11. Dynatec Labs
10.12. Steris Laboratories
10.13. Lumex Instruments
CHAPTER 11 GLOBAL BIOBURDEN TESTING MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
